Latest Stock Split Details
Key information about Oramed Pharmaceuticals Inc.'s most recent stock split
Split Date: 2013-01-23
Split Ratio: 1:12
Price Before Split: $0.63
Price After Split: $0.05
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 12.00 times fewer shares (a 1:12 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Oramed Pharmaceuticals Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2013-01-23 | 1:12 | Yes | $0.63 | $0.05 |
| 2004-06-14 | 33:10 | No | N/A | N/A |
About Oramed Pharmaceuticals Inc.
Company overview and industry information
Oramed Pharmaceuticals Inc. (ORMP) operates in the Biotechnology industry. The recent 1-for-12 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Oramed Pharmaceuticals Inc. Summary